Ultrasound screening for aortic aneurysms is vital for patients at high risk
Giselle Corbie-Smith combines the knowledge of a physician, inquisitiveness of a scientist, and outlook of an activist to ensure that research touches the lives of North Carolinians.
UNC School of Medicine's William Valdar and James Crowley lead a quest to discover the genetic underpinnings of drug side effects.
In this new series, we profile graduate students who conduct research in labs across the UNC School of Medicine. First up is Kizzmekia Corbett, who received an off-campus dissertation fellowship from the UNC Graduate School to travel to Sri Lanka. Corbett will collect blood samples to search for a specific antibody response to the dengue virus, a key step in creating a vaccine for the world's most widespread mosquito-borne disease.
A story of heart attack recognition from a UNC Cardiac Rehabilitation patient.
American Stroke Association honors outstanding contributors to stroke research
The UNC Center for Heart and Vascular Care collaborates with specialists in the Raleigh area to provide care for the most complex heart cases. (This feature was originally published in UNC Health Care's Well Magazine, Winter 2014 issue)
Researchers at the UNC Lineberger Comprehensive Cancer Center found that bladder cancer subtypes are genetically similar to breast cancer subtypes.
All UNC Hospitals and UNC Faculty Physicians clinics are closed on Friday, Feb. 14.
The research of William Powers, MD, has illuminated our understanding of stroke and guided better treatment for patients throughout three decades, a feat which earned him a Feinberg Award from the American Stroke Association.
3-year-old boy Elijah Smith had 13 surgeries in his first 2 years of life to correct lymphatic malformations. If left untreated these malformations would have caused him serious problems in breathing, eating and speaking.
A long-time nurse at UNC Hospitals and her teen-age son volunteer to cook dinner for patients and their guests at SECU Family House after being inspired by a 10-year-old boy’s commitment and action to do the same.
By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV.
The effects of this new low-molecular-weight synthetic heparin can be quickly reversed unlike the effects of low-molecular-weight heparin currently in use.
UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.